Absorbable Nasal Implant Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Absorbable Nasal Implant Devices Market by Product Type (Drug Eluting Absorbable Nasal Implant Devices, Non-Drug Eluting Nasal Implants Devices), By Material Type (Polymer, Carboxy Methyl Cellulose (CMC), Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers), and Geography.

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Absorbable nasal implant devices market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, material type, end-user and region. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged. Absorbable nasal implant devices are used in the treatment of nasal obstructions and blockage to allow better breathing. Nasal airway obstruction is caused due to enlarged turbinate, septal deviation, and vestibular stenosis among others. The most common symptoms associated with nasal airway obstruction include congestion, stuffiness, or abnormality in breathing through nostrils. Absorbable nasal implants available as spacer, springs, sponges, and gels. Absorbable implants are commonly preferred over non-absorbable implants to avoid the secondary surgery which is required to remove the non-absorbable implants. Absorbable nasal implant devices preferred over non-absorbable nasal implant devices owing to reduced adverse reactions and no delayed post-operative cosmetic changes. These devices are operated with minimally invasive techniques and have reasonable efficiency of drug-eluting implants with decrease in physiological tissue damage. Moreover, acquisitions and mergers, product approvals, and patent grants are the strategies adopted by the market players for dominating the absorbable nasal implant devices market. For instance, in July 2016, Spirox received FDA Clarence for Latera, an absorbable nasal implant to support the lower and upper lateral nasal cartilages to prevent nasal valve collapse.

Absorbable Nasal Implant Devices Market

MARKET SUMMARY
-
x
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– x%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Absorbable Nasal Implant Devices Market Analysis

  • Absorbable Nasal Implant Devices market expanding at significant CAGR over 2022 to 2028 due to growing scope of packaging in various products
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in the global Cheese Ingredients market.
  • In July 2017, Entellus Medical Acquired Spirox, Inc. for strengthening the nasal implant devices portfolio
  • in September 2015, Smith & Nephew launched Nasastent dissolvable intranasal splint to reduce the bleeding and post-operative adhesions after sinus surgery.
Market Leaders
  • Smith & Nephew plc (U.K.)
  • Pfizer, Inc. (U.S.)
  • Intersect ENT, Inc. (U.S.)
  • ArthroCare Corporation (Smith & Nephew, Inc.) (U.S.)
  • Spirox, Inc. (Entellus Medical) (U.S.)
  • Stryker Corporation (U.S.)
  • Mentor Worldwide LLC (U.S.)
  • Acclarent, Inc. (Ethicon Inc.) (U.S.)
Absorbable Nasal Implant Devices Market

Drivers and Restraints

Increase in the R&D for the innovation of novel absorbable nasal implants with advanced technologies such as decreased irritation & side effects spurs the absorbable nasal implant devices market over the forecast period. Moreover, rise in demand for absorbable nasal implants to avoid secondary surgery, adoption of advanced implants by physicians, relief from nasal congestion, and enhanced respiration ability are bolster the absorbable nasal implant devices market. However, stringent regulatory policies for product approval, product recall, mild pain and irritation with devices, and lack of awareness about absorbable implants among key stakeholders are expectd to restrain the growth of the market over the forecast years.


Absorbable Nasal Implant Devices Market

North America dominates the market

North Americaabsorbable nasal implant devices marketis growing at significant rate due to increase in R&D for the innovation of newer implants, rise in awareness about absorbable implants, and increase in healthcare expenditure in the region. Europeabsorbable nasal implant devices market is exhibiting lucrative growth owing to increase in the adoption of novel implants, rise in R&D investments for the innovation of newer devices, and increase in the nasal reconstruction surgeries in the region. Asia Pacific absorbable nasal implant devices market is poised to grow due to development in healthcare infrastructure, large patient pool, and rise in awareness about modern nasal reconstruction surgeries across the region. Latin Americaabsorbable nasal implant devices market is expected to grow positively owing to economic growth, expansion of business by market players, and adoption of technologically advanced devices in the region. Middle East and Africaabsorbable nasal implant devices market has a significant growth, which is attributed to rise in awareness about the absorbable nasal implants and increase in healthcare expenditure in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Absorbable Nasal Implant Devices Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Smith & Nephew plc (U.K.)
  • Pfizer, Inc. (U.S.)
  • Intersect ENT, Inc. (U.S.)
  • ArthroCare Corporation (Smith & Nephew, Inc.) (U.S.)
  • Spirox, Inc. (Entellus Medical) (U.S.)
  • Stryker Corporation (U.S.)
  • Mentor Worldwide LLC (U.S.)
  • Acclarent, Inc. (Ethicon Inc.) (U.S.)

Description

Absorbable nasal implant devices market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, material type, end-user and region. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged. Absorbable nasal implant devices are used in the treatment of nasal obstructions and blockage to allow better breathing. Nasal airway obstruction is caused due to enlarged turbinate, septal deviation, and vestibular stenosis among others. The most common symptoms associated with nasal airway obstruction include congestion, stuffiness, or abnormality in breathing through nostrils. Absorbable nasal implants available as spacer, springs, sponges, and gels. Absorbable implants are commonly preferred over non-absorbable implants to avoid the secondary surgery which is required to remove the non-absorbable implants. Absorbable nasal implant devices preferred over non-absorbable nasal implant devices owing to reduced adverse reactions and no delayed post-operative cosmetic changes. These devices are operated with minimally invasive techniques and have reasonable efficiency of drug-eluting implants with decrease in physiological tissue damage. Moreover, acquisitions and mergers, product approvals, and patent grants are the strategies adopted by the market players for dominating the absorbable nasal implant devices market. For instance, in July 2016, Spirox received FDA Clarence for Latera, an absorbable nasal implant to support the lower and upper lateral nasal cartilages to prevent nasal valve collapse.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX